Sitemap - 2025 - Where Tech Meets Bio

AI Meets Clinical Trials: Recent Policy Shifts & Companies to Watch

Weekly Tech+Bio Highlights #40: FDA Sets Deadline for Internal AI Rollout

Weekly Tech+Bio Highlights #39: Towards Human-Based Models

30 Companies Leveraging Big Data for Biomedical Progress

Weekly Tech+Bio Highlights #38: Predictive Models & Benchmarks

Weekly Tech+Bio Highlights #37: Turning Cells Into Language

23 New Startups in AI Drug Development Space Launched 2023–2025

Weekly Tech+Bio Highlights #36: Defining Modern AI Drug Discovery

The Rise of AI Agents in Biotech, Where Are We Now?

Weekly Tech+Bio Highlights #35: Reading the Inflection Points of AI Drug Development

Weekly Tech+Bio Highlights #34

13 Foundation Models: Startups, Industry Updates and the Nobel Prize

Weekly Tech+Bio Highlights #33: The "Holy Grail" of Digital Biology

12 Startups in the Digital Twin Healthcare Ecosystem: From Virtual Organs to Optimized Trials

Weekly Tech+Bio Highlights #32: Chemical Lab Run by Multi-Agent AI

Next Generation Sequencing: New Tech and Companies to Watch

Weekly Tech+Bio Highlights #31: Synthetic Biological Intelligence, China’s Growing Role In BCI

How Clinical Trial Design Choices Impact Speed, Risk, and Regulatory Outcomes?

Weekly Tech+Bio Highlights #30: Roche’s Comeback to Sequencing

Weekly Tech+Bio Highlights #29

Weekly Tech+Bio Highlights #28

Weekly Tech+Bio Highlights #27

Disarming Cancer's Immune Evasion, Owkin Doses First Patient With AI-Optimized Therapy

Lantern Pharma Introduces AI-Driven Antibody-Drug Conjugate Development

Moderna’s Co-Founder Links the US & UK Cambridges in Research Collaboration

Basetwo Raises $11.5M for AI-Driven, First-Principles Pharmaceutical Manufacturing Optimization

Insilico Medicine Doses First Patient With AI-Designed Pan-TEAD Inhibitor

Weekly Tech+Bio Highlights #26

FDA’s AI Drug Development Guidelines and What’s Next for Biopharma M&A